{"Symbol": "JNJ", "AssetType": "Common Stock", "Name": "Johnson & Johnson", "Description": "Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.", "CIK": "200406", "Exchange": "NYSE", "Currency": "USD", "Country": "USA", "Sector": "LIFE SCIENCES", "Industry": "PHARMACEUTICAL PREPARATIONS", "Address": "ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, US", "OfficialSite": "https://www.jnj.com", "FiscalYearEnd": "December", "LatestQuarter": "2024-12-31", "MarketCapitalization": "380153856000", "EBITDA": "30066749000", "PERatio": "17.55", "PEGRatio": "1.072", "BookValue": "29.7", "DividendPerShare": "4.96", "DividendYield": "0.033", "EPS": "8.99", "RevenuePerShareTTM": "37.13", "ProfitMargin": "0.244", "OperatingMarginTTM": "0.286", "ReturnOnAssetsTTM": "0.0813", "ReturnOnEquityTTM": "0.201", "RevenueTTM": "89330999000", "GrossProfitTTM": "61480002000", "DilutedEPSTTM": "8.99", "QuarterlyEarningsGrowthYOY": "2.387", "QuarterlyRevenueGrowthYOY": "0.024", "AnalystTargetPrice": "169.38", "AnalystRatingStrongBuy": "2", "AnalystRatingBuy": "7", "AnalystRatingHold": "13", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "17.55", "ForwardPE": "14.9", "PriceToSalesRatioTTM": "4.256", "PriceToBookRatio": "5.29", "EVToRevenue": "4.369", "EVToEBITDA": "19.74", "Beta": "0.48", "52WeekHigh": "169.99", "52WeekLow": "139.56", "50DayMovingAverage": "159.82", "200DayMovingAverage": "156.86", "SharesOutstanding": "2409850000", "DividendDate": "2025-06-10", "ExDividendDate": "2025-05-27"}